OIE Reference Laboratory Reports Activities

Similar documents
OIE Reference Laboratory Reports Activities

OIE Reference Laboratory Reports Activities

OIE Reference Laboratory Reports Activities

OIE Reference Laboratory Reports Activities

OIE Reference Laboratory Reports Activities

OIE Reference Laboratory Reports Activities

OIE Reference Laboratory Reports Activities

OIE Reference Laboratory Reports Activities

OIE Reference Laboratory Reports Activities

OIE Reference Laboratory Reports Activities

OIE Reference Laboratory Reports Activities

OIE Reference Laboratory Reports Activities

OIE Reference Laboratory Reports Activities

OIE Reference Laboratory Reports Activities

OIE Reference Laboratory Reports Activities

OIE Reference Laboratory Reports Activities

OIE Reference Laboratory Reports Activities

The definitions given below have been selected and restricted to those that are likely to be useful to users of this OIE Terrestrial Manual.

Code and manual. Aquatic animals

OIE Standard on principles and methods of validation of diagnostic assays for infectious diseases

OIE Collaborating Centres Reports Activities

OIE Reference Laboratory Reports Activities

Selection and use of Ebola in vitro diagnostic (IVD) assays

INFECTIOUS MYONECROSIS

OIE Reference Laboratory Reports Activities

OIE Reference Laboratory Reports Activities

i) Wild animals: Those animals that do not live under human supervision or control and do not have their phenotype selected by humans.

Recommendation on: The importance on pest diagnosis

OIE Guideline. International Reference Antibody Standards for Antibody Assays. 1. Introduction

BEIPH Final Report. EQA Programme 2011 Hepatitis B Virus (HBVDNA11A) William G Mackay on behalf of QCMD and its Scientific Council July 2011

Quality management in veterinary testing laboratories

SPRING VIRAEMIA OF CARP

Fifth GF-TADs for Europe Steering Committee meeting (RSC5) FAO assistance to prevent and control African Swine Fever( ASF)

EUROPEAN COMMISSION HEALTH & FOOD SAFETY. Directorate G Veterinary and International affairs. Unit G2- Animal health

APLAC GUIDELINES FOR FOOD TESTING LABORATORIES

Preparation Approval Authorisation Application date. Directive Council The President

IZSLER IMPROVING SAFETY AND SECURITY

European Technology Platform for Global Animal Health. Action Plan

OIE Regional Commission for Asia, the Far East and Oceania. Second Regional Work Plan Framework

QUALITY MANAGEMENT IN VETERINARY TESTING LABORATORIES

PPR Global Eradication Programme Overview

Development of new assays for diagnosis of West Nile virus

Joint Research Centre

WORK PROGRAMME EUROPEAN UNION REFERENCE LABORATORY FOR PARASITES. European Union Reference Laboratory for Parasites. page 1 of 15

Biosecurity and biosafety: Veterinary laboratories and animal facilities

Animal Health Laboratories Ltd,

ILAC-P10:2002. ILAC Policy on Traceability of Measurement Results

EA MULTILATERAL AGREEMENT Facilitating cross border trade with reliable goods and services

TECHNICAL DIRECTIVE PART ONE: STANDARDIZATION AND RELATED ACTIVITIES GENERAL VOCABULARY

ISTA Tests for GMO seeds : New Rules Chapter and Handbook

Public private partnerships

International standards for rabies diagnosis more than the book

Measurement of uncertainty for Elisa Tests. University of Hasselt, Center for Statistics, Hasselt, Belgium

MODULE 2D ENVIRONMENTAL MICROBIOLOGICAL LABORATORY ACCREDITATION PROGRAM (EMLAP) ADDITIONAL REQUIREMENTS

Borrelia burgdorferi

Rules for accreditation of providers of proficiency testing/interlaboratory

Standards of proficiency. Biomedical scientists

through precise environmental control, monitoring and reporting.

Role of an OIE Reference Laboratory Trichinellosis. Edoardo Pozio Istituto Superiore di Sanità Rome, Italy

Strength and spatio-temporal dynamics of resistance to phosphine and contact insecticides in key stored grain pests (3035)

BIOSAFETY AND BIOSECURITY

QuantStudio Dx Real-Time PCR Instrument

ISO/IEC INTERNATIONAL STANDARD. Conformity assessment General requirements for proficiency testing

OIE Reference Laboratory Reports Activities

BIOSAFETY AND BIOSECURITY (BSS) Series Catalog

The role of accreditation bodies and EQA organisers in the. specifications

virotype ASFV PCR Kit Handbook

OIE Guideline. 1. Introduction

Isolation of Viral RNA, Viral DNA and Bacterial DNA from Animal Samples

REPORT OF THE USAHA/AAVLD COMMITTEE ON AQUACULTURE. Co-Chairs: Dr. Andrew E. Goodwin, AR Dr. Kevin R. Snekvik, WA

Laboratory Quality Assurance Manager & Laboratory Assessor RULES & HANDBOOK

PRINCIPLES OF VALIDATION OF DIAGNOSTIC ASSAYS FOR INFECTIOUS DISEASES

Appendix1d. Review of the Programme for the Endorsement of Forest Certification schemes

ILAC Mutual Recognition Arrangement: Policy and Management ILAC-P4:06/2017

Diagnosis of Foot-and-Mouth disease virus by automated RT-PCR

Reflection paper on co-development of pharmacogenomic biomarkers and Assays in the context of drug development

Actual developments in normative regulations for Biological Resource Centers - the ISO initiatives on Biotechnology and Biorisk Management

SURVEILLANCE AND LABORATORY DIAGNOSTICS OF INFECTIOUS DISEASES IN THE RUSSIAN FEDERATION I. DYATLOV

Medical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS

ANALYTICAL STANDARDS AND REAGENTS

SADC LIVESTOCK TECHNICAL COMMITTEE MEETING (LTCM) Gaborone, Botswana, May, 2011 RECORD

Update on activities in ISO and CEN. Kirsten Mooijman

Wood Fuel Quality. Opportunities for the Wood fuel Sector. Presented by: John O Brien, Tel:

The Sophia-Antipolis Laboratory: 40 years of research and reference activities

Wildlife Health Risk Assessment in Support of Decisions and Policies

Standards of proficiency. Dietitians

INNOVATIVE STRATEGIES FOR STRENGTHENING REGIONAL ANIMAL HEALTH NETWORKS

Implementation of the VITEK MS and Its Use in Microbial Identification

The FAO-OIE PPR Global Strategy. Outline 1. Establishment of the PPR WG and actions undertaken 2. Components of the strategy

Guidelines. on imports of organic products into the European Union

Diagnostic methods for Lumpy skin disease virus LSD Expert: Dr Eeva Tuppurainen

The new ISO/IEC 17025:2017

IAF Mandatory Document. Accreditation Assessment of Conformity Assessment Bodies with Activities in Multiple Countries. Issue 2 IAF MD 12:2016

Fapas GM (GeMMA) Proficiency Testing Programme 2017

BEGINNER S GUIDE TO ISO 9001 : Quality Management System Requirements Explained

INDUSTRY S VIEW ON THE FUTURE OF IN VITRO DIAGNOSTIC (IVD) LEGISLATION IN EUROPE. May 2013 SPECIAL REPRINT. By Jesús Rueda Rodríguez, EDMA

Bioinformatics and computational tools

Published by Australian Qualifications Framework (AQF) Advisory Board PO Box 609 Carlton Vic 3053

GOVERNMENT OF THE REPUBLIC OF SIERRA-LEONE

Certified according to DIN EN ISO 9001:2008 Accredited according to DIN EN ISO/IEC 17025:2005

Transcription:

OIE Reference Laboratory Reports Activities Activities in 2015 This report has been submitted : 2016-01-14 02:24:46 Name of disease (or topic) for which you are a designated OIE Reference Laboratory: Classical swine fever Address of laboratory: 6-20-1 Josui-Honcho Kodaira Tokyo 187-0022 JAPAN Tel.: +81-42 321 14 41 Fax: +81-42 325 51 22 E-mail address: musasabi@affrc.go.jp Website: http://www.naro.affrc.go.jp/english/index.html Name (including Title) of Head of Laboratory (Responsible Official): Tomoyuki Tsuda Name (including Title and Position) of OIE Reference Expert: Shunji Yamada Which of the following defines your laboratory? Check all that apply: Research OIE Reference Laboratory Reports Activities, 2015 1

ToR 1: To use, promote and disseminate diagnostic methods validated according to OIE Standards 1. Did your laboratory perform diagnostic tests for the specified disease/topic for purposes such as disease diagnosis, screening of animals for export, surveillance, etc.? (t for quality control, proficiency testing or staff training) Diagnostic Test Indicated in OIE Manual (/) Total number of test performed last year Indirect diagnostic tests Nationally Internationally ELISA 80 0 NPLA 15 0 Neutralizing test excluded NPLA 40 0 Direct diagnostic tests Nationally Internationally Virus isolation using the detection of IFA 3 0 RT-PCR for 5'-NCR 48 0 Genetic typing using phylogenetic analysis 0 2 ToR 2: To develop reference material in accordance with OIE requirements, and implement and promote the application of OIE Standards. To store and distribute to national laboratories biological reference products and any other reagents used in the diagnosis and control of the designated pathogens or disease. 2. Did your laboratory produce or supply imported standard reference reagents officially recognised by the OIE? 3. Did your laboratory supply standard reference reagents (non OIE-approved) and/or other diagnostic reagents to OIE Member Countries? 4. Did your laboratory produce vaccines? 2 OIE Reference Laboratory Reports Activities, 2015

5. Did your laboratory supply vaccines to OIE Member Countries? ToR 3: To develop, standardise and validate, according to OIE Standards, new procedures for diagnosis and control of the designated pathogens or diseases 6. Did your laboratory develop new diagnostic methods validated according to OIE Standards for the designated pathogen or disease? 7. Did your laboratory develop new vaccines according to OIE Standards for the designated pathogen or disease? ToR 4: To provide diagnostic testing facilities, and, where appropriate, scientific and technical advice on disease control measures to OIE Member Countries 8. Did your laboratory carry out diagnostic testing for other OIE Member Countries? Name of OIE Member Country seeking assistance Date (month). samples received for provision of diagnostic support. samples received for provision of confirmatory diagnoses MONGOLIA April 10 10 MONGOLIA vember 4 4 9. Did your laboratory provide expert advice in technical consultancies on the request of an OIE Member Country? Name of the OIE Member Country receiving a technical consultancy Purpose How the advice was provided BRAZIL Support implementation of protocol for the detection of CSFV remote OIE Reference Laboratory Reports Activities, 2015 3

ToR 5: To carry out and/or coordinate scientific and technical studies in collaboration with other laboratories, centres or organisations 10. Did your laboratory participate in international scientific studies in collaboration with OIE Member Countries other than the own? ToR 6: To collect, process, analyse, publish and disseminate epizootiological data relevant to the designated pathogens or diseases 11. Did your Laboratory collect epizootiological data relevant to international disease control? 12. Did your laboratory disseminate epizootiological data that had been processed and analysed? 13. What method of dissemination of information is most often used by your laboratory? (Indicate in the appropriate box the number by category) a) Articles published in peer-reviewed journals: 0 b) International conferences: 0 c) National conferences: 0 d) Other: (Provide website address or link to appropriate information) 0 ToR 7: To provide scientific and technical training for personnel from OIE Member Countries To recommend the prescribed and alternative tests or vaccines as OIE Standards 14. Did your laboratory provide scientific and technical training to laboratory personnel from other OIE Member Countries? 4 OIE Reference Laboratory Reports Activities, 2015

ToR 8: To maintain a system of quality assurance, biosafety and biosecurity relevant for the pathogen and the disease concerned 15. Does your laboratory have a Quality Management System certified according to an International Standard? Explain Quality Management System in adoption process or currently in place ISO/IEC17025 in preparation 16. Is your laboratory accredited by an international accreditation body? 17. Does your laboratory maintain a biorisk management system for the pathogen and the disease concerned? (See Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 2014, Chapter 1.1.3a) ToR 9: To organise and participate in scientific meetings on behalf of the OIE 18. Did your laboratory organise scientific meetings on behalf of the OIE? 19. Did your laboratory participate in scientific meetings on behalf of the OIE? ToR 10: To establish and maintain a network with other OIE Reference Laboratories designated for the same pathogen or disease and organise regular inter-laboratory proficiency testing to ensure comparability of results 20. Did your laboratory exchange information with other OIE Reference Laboratories designated for the same pathogen or disease? 21. Was your laboratory involved in maintaining a network with OIE Reference Laboratories designated for the same pathogen or disease by organising or participating in proficiency tests? OIE Reference Laboratory Reports Activities, 2015 5

22. Did your laboratory collaborate with other OIE Reference Laboratories for the same disease on scientific research projects for the diagnosis or control of the pathogen of interest? ToR 11: To organise inter-laboratory proficiency testing with laboratories other than OIE Reference Laboratories for the same pathogens and diseases to ensure equivalence of results 23. Did your laboratory organise or participate in inter-laboratory proficiency tests with laboratories other than OIE Reference Laboratories for the same disease? te: See Interlaboratory test comparisons in: Laboratory Proficiency Testing at: http://www.oie.int/en/our-scientific-expertise/reference-laboratories/proficiency-testing see point 1.3 ToR 12: To place expert consultants at the disposal of the OIE 24. Did your laboratory place expert consultants at the disposal of the OIE? 25. Additional comments regarding your report: 6 OIE Reference Laboratory Reports Activities, 2015